Last reviewed · How we verify
Activated Charcoal with Sorbitol — Competitive Intelligence Brief
phase 1
Gastrointestinal adsorbent and laxative
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Activated Charcoal with Sorbitol (Activated Charcoal with Sorbitol) — Bristol-Myers Squibb. Activated charcoal adsorbs toxins and excess gases in the gastrointestinal tract, while sorbitol acts as a laxative to facilitate their removal.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Activated Charcoal with Sorbitol TARGET | Activated Charcoal with Sorbitol | Bristol-Myers Squibb | phase 1 | Gastrointestinal adsorbent and laxative |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Gastrointestinal adsorbent and laxative class)
- Bristol-Myers Squibb · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Activated Charcoal with Sorbitol CI watch — RSS
- Activated Charcoal with Sorbitol CI watch — Atom
- Activated Charcoal with Sorbitol CI watch — JSON
- Activated Charcoal with Sorbitol alone — RSS
- Whole Gastrointestinal adsorbent and laxative class — RSS
Cite this brief
Drug Landscape (2026). Activated Charcoal with Sorbitol — Competitive Intelligence Brief. https://druglandscape.com/ci/activated-charcoal-with-sorbitol. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab